1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United Kingdom >
  5. DNAFit Acquires Oxsed

M&A Deal Summary

DNAFit Acquires Oxsed

On October 30, 2020, DNAFit acquired life science company Oxsed

Acquisition Highlights
  • This is DNAFit’s 1st transaction in the Life Science sector.
  • This is DNAFit’s 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2020-10-30
Target Oxsed
Sector Life Science
Buyer(s) DNAFit
Deal Type Add-on Acquisition

Target

Oxsed

Oxford, United Kingdom
Oxsed is a social venture company that has developed a rapid COVID-19 testing platform based on research from Oxford University. Oxsed test detects SARS-CoV-19 with great sensitivity and specificity, with validated trials demonstrating a 92-100%1 positive agreement. The Oxsed testing kit has received CE mark in the EU and MHRA in the UK.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

DNAFit

London, United Kingdom
Category Company
Sector Life Science
DESCRIPTION

DNAFit Ltd. is a genetics company that reports on genetic markers related to fitness and nutrition. DNAFit is based in London, United Kingdom.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2020 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal